Почетна › Аутоимуне болести › Džordžija
Kliničke studije za Аутоимуне болести u državi Džordžija
11 studija za Аутоимуне болести traži učesnike na lokacijama u državi Džordžija.
Gradovi u državi Džordžija
Zvanični tekst studije (na engleskom)
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1014, Atlanta
- Site Number - 1043, Augusta
Тражи се учесникФаза 3
Узраст од 18 до 80 · Оба пола · Ажурирано 13. 11. 2026. · NCT07039916RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Children's Healthcare of Atlanta - Accepting Juvenile Patients, Atlanta
- Emory University - Accepting Adult Patients, Atlanta
Тражи се учесникФаза 2/3
Узраст од 6 до 75 · Оба пола · Ажурирано 13. 11. 2026. · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
- Emory University School of Medicine: Division of Rheumatology, Atlanta
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07103746A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- Children's Healthcare of Atlanta (CHOA), Atlanta
Тражи се учесникФаза 3
Узраст 12 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06056297A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Emory University, Atlanta
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06722235A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Jade Clinical Site, Atlanta
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07902817A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Emory University, Atlanta
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT06948318RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Emory University, Atlanta
Тражи се учесникФаза 1/2
Узраст од 12 до 65 · Оба пола · Ажурирано 6. 10. 2026. · NCT06121297Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
- Gastroenterology Consultants, P.C., Roswell
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 21. 9. 2026. · NCT07513181Study of BHV-1300 in Graves' Disease
- Site-104, Columbus
Тражи се учесникФаза 1
Узраст од 18 до 65 · Оба пола · Ажурирано 31. 7. 2026. · NCT06980649A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Children's Healthcare of Atlanta, Atlanta
- Northside Hospital, Atlanta
- Georgia Cancer Center at Augusta University Health, Augusta
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 6. 7. 2026. · NCT01351545Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.